o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis (Q93683456)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

title

o,p'-DDD (mitotane) treatment for Cushing's syndrome: adrenal drug concentration and inhibition in vitro of steroid synthesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference

Y Touitou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

A J Moolenaar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

A Bogdan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

A Auzéby

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

J P Luton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

9 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

page(s)

483-487

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

O,p'-DDD (mitotane) levels in plasma and tissues during chemotherapy and at autopsy.

9 May 2020

cites work

1 reference

12 December 2020

Electron carriers of the bovine adrenal cortical respiratory chain and hydroxylating pathways

1 reference

12 December 2020

Studies of the pharmacology of o,p'DDD in man.

1 reference

12 December 2020

Metabolism of o,p'-DDD (mitotane) in human and animals. Actual notions and practical deductions (author's transl)

1 reference

12 December 2020

The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring

1 reference

12 December 2020

Glucocorticoid and mineralocorticoid pathways in two adrenocortical carcinomas: comparison of the effects of o,p'-dichlorodiphenyldichloroethane, aminoglutethimide and 2-p-aminophenyl-2-phenylethylamine in vitro

1 reference

12 December 2020

Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment

1 reference

12 December 2020

Biological studies on an adrenocorticolytic agent and the isolation of the active components

1 reference

12 December 2020

Influences of op'DDD, op'DDE and solubilization procedures on the in vitro biosynthesis of 18-hydroxycorticosterone and aldosterone by sheep adrenals

1 reference

12 December 2020

Results of treatment in 108 patients with Cushing's syndrome.

1 reference

12 December 2020

Experimental evidence for biosynthesis of steroids in metastatic tissue originating from a primitive adrenocortical carcinoma

1 reference

12 December 2020

Estimation of o,p'-DDD in plasma by gas-liquid chromatography

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Changes in corticosteroid synthesis of the human adrenal cortex in vitro, induced by treatment with o,p'-DDD for Cushing's syndrome: evidence for the sites of action of the drug

1 reference

12 December 2020

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

1 reference

12 December 2020

Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.

1 reference

12 December 2020

Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00613466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4092727%20AND%20SRC:MED&resulttype=core&format=json

9 May 2020

1 reference